According to Fresenius Medical Care's latest financial reports the company's current revenue (TTM) is $21.10 B. In 2022 the company made a revenue of $20.40 B a decrease over the years 2021 revenue that were of $20.49 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $21.10 B | 3.42% |
2022 | $20.40 B | -0.42% |
2021 | $20.49 B | -0.86% |
2020 | $20.67 B | 5.77% |
2019 | $19.54 B | 0.5% |
2018 | $19.44 B | -4.74% |
2017 | $20.41 B | 6.52% |
2016 | $19.16 B | 12.1% |
2015 | $17.09 B | 4.79% |
2014 | $16.31 B | 13.59% |
2013 | $14.36 B | 6.43% |
2012 | $13.49 B | 3.3% |
2011 | $13.06 B | 6.23% |
2010 | $12.29 B | 7.63% |
2009 | $11.42 B | 6.57% |
2008 | $10.72 B | 11.87% |
2007 | $9.58 B | 15.93% |
2006 | $8.26 B | 20.79% |
2005 | $6.84 B | 17.73% |
2004 | $5.81 B | 10.33% |
2003 | $5.26 B | -1.76% |
2002 | $5.36 B | -5.26% |
2001 | $5.66 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Amgen AMGN | $28.19 B | 33.58% | ๐บ๐ธ USA |
Baxter BAX | $14.94 B | -29.16% | ๐บ๐ธ USA |
DaVita DVA | $12.14 B | -42.47% | ๐บ๐ธ USA |
IDEXX Laboratories IDXX | $3.66 B | -82.65% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $9.25 B | -56.16% | ๐บ๐ธ USA |
Teleflex TFX | $2.97 B | -85.91% | ๐บ๐ธ USA |
LabCorp LH | $12.90 B | -38.87% | ๐บ๐ธ USA |
Rockwell Medical
RMTI | $83.61 M | -99.60% | ๐บ๐ธ USA |